Journal
BIOMARKERS IN MEDICINE
Volume 10, Issue 5, Pages 525-535Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/bmm-2015-0029
Keywords
acute coronary syndrome; biomarker; myocardial infarction; prognosis
Categories
Funding
- Shanghai Key Discipline Construction Grant [ZK2012A39]
Ask authors/readers for more resources
Acute coronary syndrome (ACS), especially myocardial infarction, commonly known as a heart attack, is a serious life-threatening cardiovascular disease. Despite dramatic therapeutic advances, there have still been more than 20% patients with ACS suffering recurrent adverse cardiovascular events 3 years after disease onset. Therefore, the aim to prevent cardiac death caused by the heart attack remains challenging. Plasma biomarkers, originally developed to complement clinical assessment and electrocardiographic examination for the diagnosis of ACS, have been reported to play important prognostic roles in predicting adverse outcomes. These biomarkers mirror different pathophysiological mechanisms in association with ACS. In this review, we focus on advances of prognostic biomarkers in the past decade for short-and long-term risk assessment and management of patients with ACS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available